skip-to-main

Spikevax XBB.1.5 0.1 mg/mL dispersion for injection


Spikevax XBB.1.5 50 micrograms dispersion for injection


Spikevax XBB.1.5 50 micrograms dispersion for injection in pre-filled syringe

Spikevax XBB.1.5 is indicated for active immunisation to prevent COVID‑19 caused by SARS-CoV-2 in individuals 12 years of age and older.

Patient Information Leaflet

Summary of Product Characteristics

Spikevax bivalent Original/Omicron BA.1 (50 micrograms/50 micrograms)/mL dispersion for injection

Spikevax bivalent Original/Omicron BA.1 is indicated as a 50 microgram booster dose in adults who previously received the primary vaccination or a primary vaccination with first booster dose of an original monovalent vaccine.

Patient Information Leaflet

Summary of Product Characteristics

Spikevax (previously COVID-19 Vaccine Moderna)

Emergency Use Authorization (EUA) has been granted in Saudi Arabia for Spikevax to prevent COVID-19 (coronavirus disease 2019) in people from 6 years of age.

Patient Information Leaflet

Summary of Product Characteristics

U.S. Moderna COVID-19 Vaccine Lots and Expiry Dates and Labelling

Tools

Vial Expiration Checker

Find the expiration date for any vial of Moderna COVID-19 Vaccine through the LOT number on the vial.

Temperature Excursion Tool

See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.

Contact Moderna

8am-5pm AST – Sun - Thr
EMEAMedinfo@modernatx.com

    © 2024 Moderna, Inc.

    SA-COV-2100001 11/2023